Aspirin dose increase from 75 to 150 mg suppresses red blood cell contribution to suboptimal platelet response to aspirin in patients with CAD.

Karolczak, Kamil; Pietruszynski, Robert; Drzewoski, Jozef; Kasznicki, Jacek; Watala, Cezary

Karolczak, Kamil; Pietruszynski, Robert; Drzewoski, Jozef; Kasznicki, Jacek; Watala, Cezary.

Affiliation

Karolczak K; Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, 113 Zeromski Street, 90-549, Lodz, Poland.

Cardiovasc Drugs Ther ; 27(6): 549-58, 2013 Dec.

Article in En | MEDLINE | ID: mdl-23963688

Subject(s)

Aspirin/administration & dosage; Coronary Artery Disease/drug therapy; Platelet Aggregation Inhibitors/administration & dosage; Adult; C-Reactive Protein/analysis; Coronary Artery Disease/blood; Cross-Over Studies; Erythrocyte Count; Erythrocytes/cytology; Erythrocytes/physiology; Female; Hematocrit; Humans; Male; Middle Aged; Platelet Aggregation/drug effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Coronary Artery Disease / Platelet Aggregation Inhibitors / Aspirin Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google